Form 4: Tectonic Therapeutic Executive Receives Stock Grant
Insider Transaction (Form 4)
Marc Schwabish, Chief Business Officer of Tectonic Therapeutic, Inc., received 17,750 shares of common stock on September 3, 2026.
Summary
- Grant/award: acquired 17,750 Employee Stock Option (Right to Buy) on September 3, 2026; holds 17,750 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Marc Schwabish — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Grant/award | Employee Stock Option (Right to Buy) | 17,750 | — | — | 17,750 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Grant/award (17,750 shares) |
Keywords
insider transaction, Form 4, TECX, Tectonic Therapeutic, Inc., neutral, Marc Schwabish
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.